Validation dataset 1 (DEG model) | |||
---|---|---|---|
Level | High risk | Low risk | P value |
 | n = 31 | n = 32 |  |
Group (%) | Â | Â | Â |
 Control | 13 (41.9) | 24 (75.0) | 0.011 |
 Infected | 18 (58.1) | 8 (25.0) | |
Sex (%) | Â | Â | Â |
 Female | 13 (41.9) | 13 (40.6) | 1 |
 Male | 18 (58.1) | 19 (59.4) | |
Corrected gestational age (mean (SD)) | 236.90 (36.03) | 262.69 (35.67) | 0.006 |
Birthweight (mean (SD)) | 1863.29 (1233.33) | 2593.25 (1389.79) | 0.031 |
Validation dataset 1 (IRG model) | Â | Â | Â |
---|---|---|---|
Level | High risk | Low risk | P value |
 | n = 31 | n = 32 |  |
Group (%) | Â | Â | Â |
 Control | 9 (29.0) | 28 (87.5) |  < 0.001 |
 Infected | 22 (71.0) | 4 (12.5) | |
Sex (%) | Â | Â | Â |
 Female | 14 (45.2) | 12 (37.5) | 0.613 |
 Male | 17 (54.8) | 20 (62.5) | |
Corrected gestational age (mean (SD)) | 223.94 (28.09) | 275.25 (27.65) |  < 0.001 |
Birthweight (mean (SD)) | 1394.23 (929.43) | 3047.66 (1204.01) |  < 0.001 |
Validation dataset 2 (DEG model) | |||
---|---|---|---|
Level | High risk | Low risk | P value |
 | n = 10 | n = 10 |  |
Group (%) | Â | Â | Â |
 Control | 1 (10.0) | 5 (50.0) | 0.141 |
 Infected | 9 (90.0) | 5 (50.0) | |
 Sex (%) |  |  |  |
Female | 2 (20.0) | 2 (20.0) | 1 |
 Male | 8 (80.0) | 8 (80.0) | |
Corrected gestational age (mean (SD)) | 242.50 (18.74) | 234.40 (25.98) | 0.434 |
Birthweight (mean (SD)) | 1344.50 (309.98) | 1029.50 (385.61) | 0.059 |
Validation dataset 2 (IRG model) | |||
---|---|---|---|
Level | High risk | Low risk | P value |
 | n = 10 | n = 10 |  |
Group (%) | Â | Â | Â |
 Control | 0 (0.0) | 6 (60.0) | 0.011 |
 Infected | 10 (00.0) | 4 (40.0) | |
Sex (%) | Â | Â | Â |
 Female | 4 (40.0) | 0 (0.0) | 0.087 |
 Male | 6 (60.0) | 10 (100.0) | |
Corrected gestational age (mean (SD)) | 244.20 (24.56) | 232.70 (19.64) | 0.263 |
Birthweight (mean (SD)) | 1156.00 (348.22) | 1218.00 (420.14) | 0.724 |